B - Trademark Details
Status: 640 - Non-Final Action Counted - Not Mailed
Image for trademark with serial number 79324555
Serial Number
79324555
Word Mark
B
Status
640 - Non-Final Action Counted - Not Mailed
Status Date
2022-02-11
Filing Date
2021-05-24
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
261321, 270301 - Quadrilaterals that are completely or partially shaded. Geometric figures forming letters or numerals, including punctuation.
Law Office Assigned Location Code
M10
Employee Name
THOMAS, AMY E
Statements
Indication of Colors claimed
The color(s) blue and green is/are claimed as a feature of the mark.
Desription of the Colors Claimed
The left-slanting capital letter ?B? is blue and the parallelogram on the upper left corner of the ?B? is green.
Goods and Services
Cultures of microorganisms for medical or veterinary use; medical dressings; pharmaceuticals for human use for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceuticals for human use for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceuticals for human use for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceuticals for human use, namely, anti-infectives; antifungal pharmaceuticals for human use; Chinese traditional medicinal herbs for human use; pharmaceuticals for human use for antitussive-cold; pharmaceuticals for human use for the prevention and treatment of cancer; pharmaceuticals for human use for the treatment of psychiatric diseases and disorders; pharmaceuticals for human use for the treatment of heart rhythm disorders; medicated throat sprays for human use; diuretic pharmaceuticals for human use; pharmaceuticals for human use for the treatment of musculo-skeletal disorders; pharmaceuticals for human use for the treatment of hyperlipidemia; antitussives for human use; otorhinolaryngological pharmaceuticals for human use; anaesthetics for human use; pharmaceuticals for human, namely, antidepressants; pharmaceuticals for human use for the treatment of eye diseases and conditions; headache treatment pharmaceuticals for human use; nasal spray preparations for human use; medicines for human use for the treatment of gastrointestinal diseases; medicinal preparations for the mouth and as sprays for human use; thyroid and para-thyroid hormone pharmaceuticals for human use; sulfonamide pharmaceuticals for human use; pharmaceuticals for inhalation for the treatment of pulmonary hypertension for human use; pharmaceuticals acting on the central nervous system for human use; pharmaceuticals for human use for the treatment of erectile dysfunction; pharmaceutical solutions used in dialysis for human use; pharmaceuticals for human use for the treatment of bone diseases; antipyretic analgesics for human use; antiallergic medicines for human use; anti-diabetic pharmaceuticals for human use; hypnotic sedatives for human use; cardiovascular pharmaceuticals for medical purposes for human use; hemostatics for medical purposes for human use; antihemorrhoidal pharmaceuticals for human use; anti-epileptic pharmaceuticals for human use; cerebral hemorrhage prophylactic pharmaceuticals for human use; pharmaceuticals for human use for the treatment of immune system related diseases and disorders; pharmaceuticals for human use for treating hypertension; athlete's foot pharmaceuticals for human use; pharmaceuticals for human use for treating asthma; pharmaceuticals for human use for the treatment of hormonal disorders; medicated mouth treatment pharmaceuticals for human use; motion sickness medicines for human use; diarrhea medication for human use; pesticides; medicines for veterinary purposes, namely, pain relief medication; veterinary vaccines; anti-infectives for veterinary use; bacteriological medicines for veterinary purposes; medicines for veterinary purposes, namely, for treatment of intestinal bacteria; medicines for veterinary purposes for the treatment of animals' skin diseases; medicines for veterinary purposes for the treatment of wounds; albumin dietary supplements for medical purposes; depuratives for the body; oxygen for medical purposes; nitrous oxide for medical use; radioactive substances for medical purposes
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-11-08
Primary Code
005
Current Trademark Owners
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
UNITALEN ATTORNEYS AT LAW
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1622862
International Registration Date
2021-05-24
International Publication Date
2021-10-28
International Renewal Date
2031-05-24
Auto Protection Date
2023-04-28
International Status
001 - Request for extension of protection established
International Status Date
2021-10-29
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event DateEvent Description
2021-10-29SN ASSIGNED FOR SECT 66A APPL FROM IB
2021-11-05LIMITATION FROM ORIGINAL APPLICATION ENTERED
2021-11-08NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2021-11-12APPLICATION FILING RECEIPT MAILED
2022-02-04ASSIGNED TO EXAMINER
2022-02-11NON-FINAL ACTION WRITTEN
2022-02-12NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW